Concepedia

Adrian Gervais

AG

34

Publications

3.4K

Citations

26

H-Index

1994

Active since

Affiliations

Rockefeller University(Current)

Inserm

Institut des Maladies Génétiques Imagine

Université Paris Cité

Howard Hughes Medical Institute

Adrian Gervais is an author at Rockefeller University specializing in immunology, medicine, and autoimmunity.

ORCID

Top concepts

Publications per year

1994–2024

34

Publications

34

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Paul Bastard, Adrian Gervais, Tom Le Voyer et al. · Science Immunology · 2021 · 600 citations · Full text

X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

Takaki Asano, Bertrand Boisson, Fanny Onodi et al. · Science Immunology · 2021 · 410 citations · Full text

Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1

Paul Bastard, Elizaveta Orlova, Leila Sozaeva et al. · The Journal of Experimental Medicine · 2021 · 295 citations · Full text

, , +14

Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19

Monique G.P. van der Wijst, Sara E. Vazquez, George C. Hartoularos et al. · Science Translational Medicine · 2021 · 231 citations · Full text

, , +21

Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine

Paul Bastard, Eleftherios Michailidis, Hans-Heinrich Hoffmann et al. · The Journal of Experimental Medicine · 2021 · 224 citations · Full text

Rows per page

1–5 of 34